CABOLONG, available in 20 mg and 60 mg tablets, is an oral formulation of Cabozantinib, a powerful multi-kinase inhibitor used in the treatment of several solid tumors. This targeted therapy plays a crucial role in managing advanced cancers like renal cell carcinoma (RCC), hepatocellular carcinoma (HCC), and medullary thyroid cancer (MTC). By inhi